Biotest's total assets for Q4 2024 were €1.43B, an increase of 6.48% from the previous quarter. GB:0N6Z total liabilities were €903.30M for the fiscal quarter, a 10.27% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.